Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

654 ARTÍCULOS , VIENDO DEL 391 AL 405

Blood based biomarkers for movement disorders

Morris HR.

Acta Neurol Scand. 2022 Oct;146(4):353-361. doi: 10.1111/ane.13700.

How well do you know your dopamine antagonists?

2022 Oct. Perry T, editor. Therapeutics Letter. Vancouver (BC): Therapeutic Initiatives; 1994–. Letter 139.

Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial

Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, McKee KE, Goelz L, Poon C, Tilley B, Kang UJ, Tansey MG, Luthra N, Tanner CM, Haus JM, Fantuzzi G, McFarland NR, Gonzalez-Latapi P, Foroud T, Motl R, Schwarzschild MA, Simuni T, Marek K, Naito A, Lungu C, Corcos DM; SPARX3-PSG Investigators.

Trials. 2022 Oct 6;23(1):855. doi: 10.1186/s13063-022-06703-0.

Impact of Covid-19 on research and training in Parkinson's disease

Wan YM, van Wamelen DJ, Lau YH, Rota S, Tan EK.

Int Rev Neurobiol. 2022;165:283-305. doi: 10.1016/bs.irn.2022.04.003. Epub 2022 May 4.

Deep Brain Stimulation in the Treatment of Parkinson's Disease

Shah H, Usman O, Ur Rehman H, Jhaveri S, Avanthika C, Hussain K, Islam H, I S K S.

Cureus. 2022 Sep 3;14(9):e28760. doi: 10.7759/cureus.28760. eCollection 2022 Sep.

An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation

Serva SN, Bernstein J, Thompson JA, Kern DS, Ojemann SG.

Front Surg. 2022 Sep 23;9:863921. doi: 10.3389/fsurg.2022.863921. eCollection 2022.

Community-based high-intensity cycling improves disease symptoms in individuals with Parkinson's disease: A six-month pragmatic observational study

Rosenfeldt AB, Miller Koop M, Penko AL, Hastilow K, Zimmerman E, Schindler D, Alberts JL.

Health Soc Care Community. 2022 Nov;30(6):e6122-e6134. doi: 10.1111/hsc.14049. Epub 2022 Oct 10.

Diagnosis and Medical Management of Parkinson Disease

Thaler A, Alcalay RN.

Continuum (Minneap Minn). 2022 Oct 1;28(5):1281-1300. doi: 10.1212/CON.0000000000001152.

Palliative Care and Movement Disorders

Katz M.

Continuum (Minneap Minn). 2022 Oct 1;28(5):1520-1529. doi: 10.1212/CON.0000000000001162.

[MRI Findings in Parkinson's Disease: Radiologic Assessment of Nigrostriatal Degeneration]

Bae YJ, Kim JM, Choi BS, Song YS, Nam Y, Cho SJ, Kim JH, Kim SE.

Taehan Yongsang Uihakhoe Chi. 2022 May;83(3):508-526. doi: 10.3348/jksr.2022.0044. Epub 2022 May 25.

Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease

Mehanna R, Smilowska K, Fleisher J, Post B, Hatano T, Pimentel Piemonte ME, Kumar KR, McConvey V, Zhang B, Tan EK, Savica R; International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease.

Mov Disord Clin Pract. 2022 Sep 10;9(7):869-878. doi: 10.1002/mdc3.13523. eCollection 2022 Oct.

Nilotinib in Parkinson's disease: A systematic review and meta-analysis

Xie X, Yuan P, Kou L, Chen X, Li J, Li Y.

Front Aging Neurosci. 2022 Sep 29;14:996217. doi: 10.3389/fnagi.2022.996217. eCollection 2022.

The role of neurotransmitter systems in mediating deep brain stimulation effects in Parkinson's disease

Alosaimi F, Boonstra JT, Tan S, Temel Y, Jahanshahi A.

Front Neurosci. 2022 Oct 5;16:998932. doi: 10.3389/fnins.2022.998932. eCollection 2022.

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial

Stevens KN, Creanor S, Jeffery A, Whone A, Zajicek J, Foggo A, Jones B, Chapman R, Cocking L, Wilks J, Webb D, Carroll C; PD STAT Study Group.

JAMA Neurol. 2022 Dec 1;79(12):1232-1241. doi: 10.1001/jamaneurol.2022.3718.

Gait and axial postural abnormalities correlations in Parkinson's disease: A multicenter quantitative study

Pongmala C, Fabbri M, Zibetti M, Pitakpatapee Y, Wangthumrong T, Sangpeamsook T, Srikajon J, Srivanitchapoom P, Youn J, Cho JW, Kim M, Zamil Shinawi HM, Obaid MT, Baumann A, Margraf NG, Pona-Ferreira F, Leitão M, Lobo T, Ferreira JJ, Lopiano L, Artusi CA.

Parkinsonism Relat Disord. 2022 Dec;105:19-23. doi: 10.1016/j.parkreldis.2022.10.026. Epub 2022 Oct 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias